CryoPort Selects Federal Express as Its Global Shipping Partner

LAKE FOREST, CA -- (MARKET WIRE) -- 12/19/07 -- CryoPort, Inc. (OTCBB: CYRX) today announced that it has named Federal Express (FedEx) as its global shipping provider for the ramp-up of the CryoPort Express system.

Peter Berry, CryoPort's CEO, commented, "We are pleased to be working with Federal Express as we build the infrastructure to support the one-way shipper system. FedEx's global reach and service capabilities will help ensure excellent service for our customers in the biopharma, clinical trials and laboratory services markets."

About CryoPort, Inc.

CryoPort (www.cryoport.com) develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold shipping chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

"SAFE HARBOR"

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Stuart Fine
Carpe DM, Inc.
908-469-1788